PRECEDE

Enrolling By Invitation
99 years or below
Female
Phase 3
1 Location

Brief description of study

This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either azithromycin prophylaxis or to placebo. All participants will receive standard of care preoperative antibiotics.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pregnancy, Cesarean delivery
  • Age: 99 years or below
  • Gender: Female
Updated on 30 Mar 2026. Study ID: 24-1703
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research